Reagents and methods useful for detecting diseases of the prostate
CA 2303404 A1 · Owner: Russell, John C. · Inventors: Hodges, Steven C.; Billing-Medel, Patricia A.; Cohen, Maurice
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Sequences useful for the detecting, diagnosing staging, monitoring, prognosticating, in vivo imaging preventing or treating, or determining the predisposition of an individual to diseases and conditions of the prostate such as prostate cancer, are described. These sequences are designated as PS213 sequences herein. Also provided are antibodies which specifically bind to PS213-encoded polypeptide or protein and agonists or inhibitors which , prevent action of the tissue-specific PS213 polypeptide which molecules are , useful for the therapeutic treatment of prostate diseases tumors or , metastases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 11, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 11, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 11, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.